The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy
Open accessAbstract
For cancer patients with chronic hepatitis B virus (HBV) infection, who receive cytotoxic chemotherapy, HBV reactivation is a well-described complication, which may result in varying degrees of liver damage. Several clinical features and the pre-chemotherapy HBV viral load have been suggested to be associated with an increased risk of developing the condition: (1). to assess the clinical and virological factors in a comprehensive manner and thereby identify those that are associated with the development of HBV reactivation; (2). to develop a predictive model to quantify the risk of HBV reactivation. In all, 138 consecutive cancer patients who were HBV carriers and undergoing chemotherapy were studied, of which 128 patients had sera available for real-time PCR HBV DNA measurement. They were followed up throughout their course of chemotherapy and the HBV reactivation rate was determined. The clinical and virological features between those who did and did not develop viral reactivation were compared. These included age, sex, baseline liver function tests, HBeAg status and viral load (HBV DNA) prior to the chemotherapy, and the use of specific cytotoxic agents. In all, 36 (26%) developed HBV reactivation. Multivariate analysis revealed pre-chemotherapy HBV DNA level, the use of steroids and a diagnosis of lymphoma or breast cancer to be significant factors. Based on real-time HBV DNA PCR assay, detectable baseline HBV DNA prior to the administration of cytotoxic chemotherapy, the use of steroids and a diagnosis of lymphoma or breast cancer are predictive factors for the development of HBV reactivation. A predictive model was developed from the current data, based on a logistic regression method.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2011) · Hepatogastroenterology · doi:10.5754/hge11453 · Cited by 1,254
Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy
Lok, A. S. F., Liang, R. H. S., Chiu, E. K. W., Wong, K.-L., Chan, T.-K., & Todd, D. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90599-g · Cited by 827
Receiver operating characteristic (ROC) methodology: the state of the art.
Hanley, J. A. (1989) · PubMed · Cited by 807
Yeo, W., Chan, P. K. S., Zhong, S., Ho, W. M., Steinberg, J. L., Tam, J. S., Hui, P., Leung, N. W. Y., Zee, B., & Johnson, P. J. (2000) · Journal of Medical Virology · doi:10.1002/1096-9071(200011)62:3<299::aid-jmv1>3.0.co;2-0 · Cited by 627
Self-citationFisher, B., Brown, A. M., Dimitrov, N. V., Poisson, R., Redmond, C., Margolese, R. G., Bowman, D., Wolmark, N., Wickerham, D. L., & Kardinal, C. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.9.1483 · Cited by 620
Omata, M., Ehata, T., Yokosuka, O., Hosoda, K., & Ohto, M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106133242404 · Cited by 523
Reactivation of Chronic Hepatitis B Virus Infection by Cancer Chemotherapy
Hoofnagle, J. H., Dusheiko, G. M., Schafer, D. F., Jones, E. A., Micetich, K. C., Young, R. C., & Costa, J. C. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-4-447 · Cited by 396
Lau, G. K. K., Leung, Y.-H., Fong, D. Y. T., Au, W.-Y., Kwong, Y.-L., Lie, A., Hou, J.-L., Wen, Y.-M., Nanj, A., & Liang, R. (2002) · Blood · doi:10.1182/blood.v99.7.2324 · Cited by 233
Liaw, Y., Tai, D., Chu, C., Pao, C. C., & Chen, T. (1987) · Hepatology · doi:10.1002/hep.1840070106 · Cited by 156
Ehata, T., Omata, M., Chuang, W., Yokosuka, O., Ito, Y., Hosoda, K., & Ohto, M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116281 · Cited by 140
Cited by
Terrault, N. A., Lok, A. S. F., McMahon, B. J., Chang, K., Hwang, J. P., Jonas, M. M., Brown, R. S., Bzowej, N. H., & Wong, J. B. (2018) · Hepatology · doi:10.1002/hep.29800 · Cited by 4,306
Bernal, W., Auzinger, G., Dhawan, A., & Wendon, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60274-7 · Cited by 996
EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure
Wendon, J., Cordoba, J., Dhawan, A., Larsen, F. S., Manns, M., Nevens, F., Samuel, D., Simpson, K. J., Yaron, I., & Bernardi, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.003 · Cited by 917
Reddy, K. R., Beavers, K. L., Hammond, S. P., Lim, J. K., & Falck-Ytter, Y. T. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.10.039 · Cited by 861
Yeo, W., Chan, T. C., Leung, N. W. Y., Lam, W. Y., Mo, F. K. F., Chu, M. T., Chan, H. L. Y., Hui, E. P., Lei, K. I. K., Mok, T. S. K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.0182 · Cited by 636
Self-citationLoomba, R., & Liang, T. J. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.02.009 · Cited by 594
Yeo, W., Mok, T. S., Zee, B., Leung, T. W. T., Lai, P. B. S., Lau, W. Y., Koh, J., Mo, F. K. F., Yu, S. C. H., Chan, A. T., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji315 · Cited by 590
Self-citationReactivation of hepatitis B # †
Hoofnagle, J. H. (2009) · Hepatology · doi:10.1002/hep.22945 · Cited by 570
Perrillo, R. P., Gish, R., & Falck-Ytter, Y. T. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.10.038 · Cited by 504
Huang, Y.-H., Hsiao, L.-T., Hong, Y.-C., Chiou, T.-J., Yu, Y.-B., Gau, J.-P., Liu, C.-Y., Yang, M.-H., Tzeng, C.-H., Lee, P.-C., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5938 · Cited by 326
Lalazar, G., Rund, D., & Shouval, D. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06465.x · Cited by 311
Hsu, C., Hsiung, C. A., Su, I.-J., Hwang, W.-S., Wang, M.-C., Lin, S.-F., Lin, T.-H., Hsiao, H.-H., Young, J.-H., Chang, M.-C., et al. (2008) · Hepatology · doi:10.1002/hep.22106 · Cited by 305
Rituximab-related viral infections in lymphoma patients
Aksoy, S., Harputluoglu, H., Kilickap, S., Dede, D. S., Dizdar, O., Altundag, K., & Barista, I. (2007) · Leukemia & Lymphoma · doi:10.1080/10428190701411441 · Cited by 253
Metadata
- Authors
- Yeo, W., Zee, B., Zhong, S., Chan, P. K. S., Wong, W.-L., Ho, W. M., Lam, K. C., & Johnson, P. J.
- Venue
- British Journal of Cancer
- Published
- 2004-03-09
- Volume
- 90
- Issue
- 7
- Pages
- 1306-1311
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2012007321
- Cited by
- 312
- References
- 13
- FWCI
- 6.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.